Frontlight ResearchEarly access
Active, not recruitingNo phase
Microwave Ablation of Uterine Fibroids
Key facts
- Who runs it
- Turku University Hospital
- Where
- Finland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 100 people, planned
- Started
- 1 May 2026
- Expected to end
- Dec 2034
- Type of study
- Observational
- Treatments tested
- microwave ablation
- Record updated
- 21 August 2026
Who can take part
- Age
- 18 years to 56 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- symptomatic fibroids
- premenopausal status
- acceptable risks for general anestesia or sedation
- willing to undergo mwa treatment and participate in the study
Who cannot take part
- bleeding disorder with increased risk of bleeding
- postmenopausal status
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective observational study aims to evaluate the effectiveness and acceptability of percutaneous or vaginal ultrasound guided microwave ablation for the treatment or symptomatic uterine fibroids. We will include 100 women.
The group in the trial
- patients with symptomatic uterine fibroids
Patients with symptomatic uterine fibroids, who will undergo microwave ablation of fibroids as a clinical treatment are recruited in this study.
Treatment: microwave ablation
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective Observational Study of Microwave Ablation of Uterine Fibroids (MyoMwa)
- Record updated
- 21 August 2026